TrialBreast cancer research and treatment2013

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer.

Shanu Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.